# Yuichiro� Doki

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/yuichiro-doki/

## Facts

| Field | Value |
| --- | --- |
| Citations | 52,620 |
| Field | Esophageal Cancer Research and Treatment |
| h-index | 103 |
| i10-index | 942 |
| Last Known Institution | Osaka Gakuin University |
| OpenAlex ID | https://openalex.org/A5028284770 |
| ORCID iD | 0000-0001-7346-0209 |
| Works | 2,275 |

## Researcher papers

Showing 12 of 17.

- [Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial](https://scholariq.org/papers/nivolumab-versus-chemotherapy-in-patients-with-advanced-oesophageal-squamous/)
- [Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers](https://scholariq.org/papers/two-foxp3-cd4-t-cell-subpopulations-distinctly-control-the-prognosis-of/)
- [Reprogramming of Mouse and Human Cells to Pluripotency Using Mature MicroRNAs](https://scholariq.org/papers/reprogramming-of-mouse-and-human-cells-to-pluripotency-using-mature-micrornas/)
- [CD13 is a therapeutic target in human liver cancer stem cells](https://scholariq.org/papers/cd13-is-a-therapeutic-target-in-human-liver-cancer-stem-cells/)
- [Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2](https://scholariq.org/papers/esophageal-cancer-practice-guidelines-2017-edited-by-the-japan-esophageal/)
- [Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1](https://scholariq.org/papers/esophageal-cancer-practice-guidelines-2017-edited-by-the-japan-esophageal-2/)
- [Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma](https://scholariq.org/papers/nivolumab-combination-therapy-in-advanced-esophageal-squamous-cell-carcinoma/)
- [Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer](https://scholariq.org/papers/exosomal-microrna-in-serum-is-a-novel-biomarker-of-recurrence-in-human/)
- [Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society](https://scholariq.org/papers/guidelines-for-diagnosis-and-treatment-of-carcinoma-of-the-esophagus-april-2012/)
- [Thoracic and cardiovascular surgery in Japan during 2014](https://scholariq.org/papers/thoracic-and-cardiovascular-surgery-in-japan-during-2014/)
- [Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma](https://scholariq.org/papers/circulating-microrna-21-as-a-novel-biomarker-for-hepatocellular-carcinoma/)
- [Genomic Landscape of Esophageal Squamous Cell Carcinoma in a Japanese Population](https://scholariq.org/papers/genomic-landscape-of-esophageal-squamous-cell-carcinoma-in-a-japanese-population/)

## Researcher topics

- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Colorectal Cancer Surgical Treatments](https://scholariq.org/topics/colorectal-cancer-surgical-treatments/)
- [Esophageal and GI Pathology](https://scholariq.org/topics/esophageal-and-gi-pathology/)

## Researcher university

- [Osaka Gakuin University](https://scholariq.org/institutions/osaka-gakuin-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.